Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative daptomycin tissue and serum concentrations in elective orthopedic surgery
2007-004990-24Phase 3Active
- Sponsor
- University Hospital Freiburg
- Start
- Dec 2007
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of daptomycin in surgical site infection (SSI), sponsored by University Hospital Freiburg. Primary endpoint: Daptomycin concentrations in serum and tissues. Started Dec 2007; status: active.
02
Drugs
daptomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on 2007-004990-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004990-24.